Pattwell, S. S., Arora, S., Cimino, P. J., Ozawa, T., Szulzewsky, F., Hoellerbauer, P., . . . Holland, E. C. (2020). A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways. Nat Commun.
Chicago Style citaatPattwell, Siobhan S., et al. "A Kinase-deficient NTRK2 Splice Variant Predominates in Glioma and Amplifies Several Oncogenic Signaling Pathways." Nat Commun 2020.
MLA citatiePattwell, Siobhan S., et al. "A Kinase-deficient NTRK2 Splice Variant Predominates in Glioma and Amplifies Several Oncogenic Signaling Pathways." Nat Commun 2020.
Let op: Deze citaties zijn niet altijd 100% accuraat.